Singular Genomics Systems, Inc. (OMIC)
NASDAQ: OMIC · IEX Real-Time Price · USD
0.400
-0.007 (-1.74%)
At close: May 2, 2024, 3:59 PM
0.395
-0.005 (-1.25%)
After-hours: May 2, 2024, 4:00 PM EDT
Singular Genomics Systems Revenue
In the year 2023, Singular Genomics Systems had annual revenue of $2.91M with 280.52% growth. Revenue in the quarter ending December 31, 2023 was $1.08M with 41.31% year-over-year growth.
Revenue (ttm)
$2.91M
Revenue Growth
+280.52%
P/S Ratio
10.43
Revenue / Employee
$11,416
Employees
255
Market Cap
29.63M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.91M | 2.15M | 280.52% |
Dec 31, 2022 | 765.00K | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Concord Medical Services Holdings | 75.80M |
Qilian International Holding Group | 46.47M |
DURECT | 8.55M |
Palatin Technologies | 7.10M |
NeuroOne Medical Technologies | 2.82M |
bioAffinity Technologies | 2.53M |
Femasys | 1.07M |
Lexaria Bioscience | 386.00K |
OMIC News
- 6 weeks ago - Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 2 months ago - Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 - GlobeNewsWire
- 3 months ago - Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform - GlobeNewsWire
- 3 months ago - Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis - GlobeNewsWire
- 4 months ago - Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue - GlobeNewsWire
- 6 months ago - Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results - GlobeNewsWire
- 6 months ago - Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023 - GlobeNewsWire
- 8 months ago - Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase - GlobeNewsWire